BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32571430)

  • 1. IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection.
    Lamberet A; Rostan O; Dion S; Jan A; Guegan H; Manuel C; Samson M; Gangneux JP; Robert-Gangneux F
    Parasit Vectors; 2020 Jun; 13(1):320. PubMed ID: 32571430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
    Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
    mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
    Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
    Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
    Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
    J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
    Basu A; Chakrabarti G; Saha A; Bandyopadhyay S
    Immunology; 2000 Feb; 99(2):305-13. PubMed ID: 10692051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes.
    Mukherjee P; Ghosh AK; Ghose AC
    Immunol Lett; 2003 Apr; 86(2):131-8. PubMed ID: 12644314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo immunomodulatory properties of octyl-β-D-galactofuranoside during Leishmania donovani infection.
    Guegan H; Ory K; Belaz S; Jan A; Dion S; Legentil L; Manuel C; Lemiègre L; Vives T; Ferrières V; Gangneux JP; Robert-Gangneux F
    Parasit Vectors; 2019 Dec; 12(1):600. PubMed ID: 31870416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.
    Alexander CE; Kaye PM; Engwerda CR
    Eur J Immunol; 2001 Apr; 31(4):1199-210. PubMed ID: 11298345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.
    Melby PC; Yang YZ; Cheng J; Zhao W
    Infect Immun; 1998 Jan; 66(1):18-27. PubMed ID: 9423834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.
    Mullen AB; Lawrence CE; McFarlane E; Wei XQ; Carter KC
    Immunology; 2006 Nov; 119(3):348-54. PubMed ID: 16879623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani.
    Kumar S; Bodhale N; Patra SK; Sarode A; Zhao L; Sarkar A; Saha B
    Cytokine; 2024 Feb; 174():156475. PubMed ID: 38134556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inbred mouse strains differentially susceptible to Leishmania donovani infection differ in their immune cell metabolism.
    Bodhale NP; Pal S; Kumar S; Chattopadhyay D; Saha B; Chattopadhyay N; Bhattacharyya M
    Cytokine; 2018 Dec; 112():12-15. PubMed ID: 29885992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.
    Basu R; Bhaumik S; Haldar AK; Naskar K; De T; Dana SK; Walden P; Roy S
    Infect Immun; 2007 Dec; 75(12):5956-66. PubMed ID: 17908806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis.
    Das P; Amit A; Singh SK; Chaudhary R; Dikhit MR; Yadav A; Pandey K; Das VN; Sundram S; Das P; Bimal S
    Parasitol Int; 2015 Feb; 64(1):18-25. PubMed ID: 25224164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis.
    Oghumu S; Gupta G; Snider HM; Varikuti S; Terrazas CA; Papenfuss TL; Kaplan MH; Satoskar AR
    Eur J Immunol; 2014 Feb; 44(2):450-9. PubMed ID: 24242758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.
    Murray HW; Hariprashad J; Coffman RL
    J Exp Med; 1997 Mar; 185(5):867-74. PubMed ID: 9120392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-21 Deficiency Promotes the Early Th1 Immune Response and Resistance toward Visceral Leishmaniasis.
    Varikuti S; Verma C; Holcomb E; Jha BK; Viana A; Maryala R; Lamenza F; McElwain BK; Doni NY; Papenfuss T; Oghumu S; Gannavaram S; Nakhasi HL; Satoskar AR
    J Immunol; 2021 Sep; 207(5):1322-1332. PubMed ID: 34341171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
    Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
    Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.